Bio-IT World: Venture, Innovation & Partnering 2024 | Cambridge Innovation Institute | 17 April 2024 | Omni Boston Hotel at the Seaport, 450 Summer St, Boston, MA 02210, USA

This exclusive event is tailor-made for Venture Capitalists, Private Equity professionals, Banks Investors, and CEOs steering the helm of Tech Bio, Bio-Tech, and Large Pharma enterprises. Join us to foster collaboration, share insights on strategic investments in cutting-edge technologies, and gain a comprehensive understanding of the latest funding activities and noteworthy exits. Seize this unparalleled opportunity to delve into the intricate landscape of biotech investments, discover who is leading the charge in groundbreaking technologies, and explore the commercialization of emerging solutions tackling industry challenges head-on.

Topics Include:

• Investment Trends in Bio-IT
• CEO Perspectives on Raising Capital
• AI as Investable Thesis for Drug R&D and Commercialization
• Building a Data Science Organization: Effectiveness and Impact
• Nurturing Innovation: Biotech Incubator Investments
• Boston and Cambridge- Biotech Hub—How to sustain as an Investment Powerhouse?

Who Should Attend

INVESTMENT FIRMS:
• Venture Capitalists
• Private Equity Firms
• Investment Banks
• Senior Investors (Managing Partners/Directors & General Partners)
• Investors (Partners, Investors & Principals)
• Private Marketing Investing
• Portfolio Advisors (Venture & Operating Partners)

Startups and Growth Companies:
• Emerging Company Leaders
• Founders & CEOs
• C-Suite Executives (CFOs, CSOs, CIOs, CTOs, etc.)
• Innovation & Strategy Managers (SVPs, VPs & Directors)

CORPORATIONS:
• IT, Technology, Data, Informatics, Software Executives
• Hospitals (Venture & Innovation)
• Large Pharma (Venture & Innovation
• Business Development Heads (SVPs, VPs & Directors)
• Innovation & Strategy Managers (SVPs, VPs & Directors)
• Corporate Venture Leaders (Managing Directors, Partners & Directors)

2024 Speakers

CO-CHAIRS:

William Mayo
Senior Vice President Research, IT, Bristol Myers Squibb

John Keilty
Venture Partner, Third Rock

Jami Rubin
CFO, Boundless Bio and Venture Partner,, ARCH Venture Partners

SPEAKERS:

Joe Collura
Portal Innovations

Brett B Cook
F Prime Capital

Jason Cordeiro
Massachusetts Biotechnology Council

Cris De Luca
Sanofi Ventures

Daniel Franke
M Ventures

Molly Gibson
Flagship Pioneering

Luba Greenwood
Binney Street Capital, Dana-Farber Cancer Institute

Sofia Guerra
Bessemer Venture Partners

Yvonne Hao
Commonwealth of Massachusetts

Lisa Hughes
CBS Boston

John J Keilty
Third Rock Ventures LLC

Dave Latshaw
BioPhy

Rana Lonnen
Novartis

William Mayo

Erin McKenna
Mass General Brigham Innovation

Eileen Murphy
Cambridge Healthtech Institute

Kimberly Nearing
BVCF

Mika Newton
xCures

Tom Neyarapally
Archetype Therapeutics, Inc.

Stephanie Oestreich
Myeloma Investment Fund of the MMRF

Stephen Pagliuca
PagsGroup

Scott Penberthy
Google Cloud

Trevor Perry
Selas Ventures

Imogen Pryce
Relay Therapeutics Inc

Jami Rubin
Boundless BIo/ Arch Venture

Miruna Sasu
COTA Inc

Michael R Schlabach
Curie.Bio

Chris Shibutani
Goldman Sachs

Joe Shonkwiler
Advanced Research Projects Agency for Health (ARPA-H)

Mats T Sundgren
European Institute for Innovation through Health Data

Zachary Taft
Memorial Sloan Kettering

Jo L Viney
Seismic Therapeutic

Christina Vorvis
AbbVie Ventures

Xiaoying Wu
Janssen Pharmaceuticals Inc